EverSource Wealth Advisors LLC Purchases 3,482 Shares of The Procter & Gamble Company (NYSE:PG)

EverSource Wealth Advisors LLC increased its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 48.2% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,700 shares of the company’s stock after acquiring an additional 3,482 shares during the period. EverSource Wealth Advisors LLC’s holdings in Procter & Gamble were worth $1,746,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the stock. Norges Bank bought a new stake in shares of Procter & Gamble in the 4th quarter valued at about $3,956,117,000. Charles Schwab Investment Management Inc. lifted its stake in shares of Procter & Gamble by 1.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company’s stock valued at $2,336,552,000 after purchasing an additional 206,165 shares during the period. Fisher Asset Management LLC lifted its stake in shares of Procter & Gamble by 5.6% in the 4th quarter. Fisher Asset Management LLC now owns 10,556,988 shares of the company’s stock valued at $1,547,021,000 after purchasing an additional 559,358 shares during the period. Franklin Resources Inc. lifted its stake in shares of Procter & Gamble by 2.6% in the 4th quarter. Franklin Resources Inc. now owns 9,571,693 shares of the company’s stock valued at $1,402,636,000 after purchasing an additional 246,323 shares during the period. Finally, California Public Employees Retirement System lifted its stake in shares of Procter & Gamble by 17.1% in the 4th quarter. California Public Employees Retirement System now owns 9,492,039 shares of the company’s stock valued at $1,390,963,000 after purchasing an additional 1,387,539 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 2.6 %

Shares of PG stock traded up $4.39 during trading hours on Friday, reaching $170.08. The company had a trading volume of 11,899,038 shares, compared to its average volume of 6,952,473. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.73 and a quick ratio of 0.48. The company has a market cap of $401.41 billion, a price-to-earnings ratio of 27.79, a price-to-earnings-growth ratio of 3.60 and a beta of 0.41. The business has a fifty day simple moving average of $166.28 and a 200-day simple moving average of $162.13. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $170.92.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating analysts’ consensus estimates of $1.37 by $0.03. The company had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a return on equity of 33.33% and a net margin of 17.71%. Procter & Gamble’s revenue was down .1% on a year-over-year basis. During the same period last year, the business posted $1.37 earnings per share. On average, research analysts expect that The Procter & Gamble Company will post 6.96 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.37%. The ex-dividend date is Friday, July 19th. Procter & Gamble’s payout ratio is 65.85%.

Insider Activity at Procter & Gamble

In related news, CEO Gary A. Coombe sold 21,388 shares of the stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $164.98, for a total transaction of $3,528,592.24. Following the completion of the sale, the chief executive officer now directly owns 36,854 shares of the company’s stock, valued at $6,080,172.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Procter & Gamble news, CEO Sundar G. Raman sold 31,924 shares of the firm’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $166.95, for a total value of $5,329,711.80. Following the completion of the sale, the chief executive officer now directly owns 19,042 shares of the company’s stock, valued at $3,179,061.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Gary A. Coombe sold 21,388 shares of the firm’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $164.98, for a total value of $3,528,592.24. Following the completion of the sale, the chief executive officer now directly owns 36,854 shares of the company’s stock, valued at $6,080,172.92. The disclosure for this sale can be found here. Over the last three months, insiders sold 94,320 shares of company stock valued at $15,646,323. 0.17% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and dropped their price objective for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. Evercore ISI boosted their price objective on Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. TD Cowen assumed coverage on Procter & Gamble in a research note on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price objective on the stock. Royal Bank of Canada upped their price target on Procter & Gamble from $157.00 to $164.00 and gave the stock a “sector perform” rating in a research note on Wednesday. Finally, BNP Paribas assumed coverage on Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $173.95.

Get Our Latest Analysis on PG

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.